BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22246850)

  • 21. Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events.
    Zhu YM; Verma S; Fung M; McQueen MJ; Anderson TJ; Lonn EM
    Can J Cardiol; 2017 Oct; 33(10):1305-1311. PubMed ID: 28941609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
    Couce ML; Vitoria I; Aldámiz-Echevarría L; Fernández-Marmiesse A; Roca I; Llarena M; Sánchez-Pintos P; Leis R; Hermida A
    Orphanet J Rare Dis; 2016 Sep; 11(1):123. PubMed ID: 27612877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children.
    Galcheva SV; Iotova VM; Yotov YT; Bernasconi S; Street ME
    Eur J Endocrinol; 2011 Apr; 164(4):553-8. PubMed ID: 21224406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios.
    Diaf M; Khaled BM; Sellam F
    Libyan J Med; 2015; 10(1):27400. PubMed ID: 25959906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.
    Baker JV; Neuhaus J; Duprez D; Cooper DA; Hoy J; Kuller L; Lampe FC; Liappis A; Friis-Moller N; Otvos J; Paton NI; Tracy R; Neaton JD;
    AIDS; 2011 Nov; 25(17):2133-42. PubMed ID: 21857489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifestyle and Dietary Determinants of Serum Apolipoprotein A1 and Apolipoprotein B Concentrations: Cross-Sectional Analyses within a Swedish Cohort of 24,984 Individuals.
    Frondelius K; Borg M; Ericson U; Borné Y; Melander O; Sonestedt E
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyslipidemia in diabetes: a population-based study in Bali.
    Suastika K; Semadi IMS; Dwipayana IMP; Saraswati MR; Gotera W; Budhiarta AAG; Matsumoto K; Kajiwara N; Taniguchi H
    Int J Gen Med; 2019; 12():313-321. PubMed ID: 31564954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A; Parkhideh S; Sarrafzadegan N; Asgary S; Williams K; Jungner I; Aastveit A; Walldius G; Sniderman A
    Atherosclerosis; 2009 Nov; 207(1):200-7. PubMed ID: 19766218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atherogenic index of plasma is increased by hormonal contraception.
    Soska V; Fiala J; Nebeska K; Jarkovsky J; Hruba D
    Scand J Clin Lab Invest; 2011 Apr; 71(2):94-100. PubMed ID: 21261509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.
    Kostapanos MS; Christogiannis LG; Bika E; Bairaktari ET; Goudevenos JA; Elisaf MS; Milionis HJ
    J Stroke Cerebrovasc Dis; 2010; 19(6):497-502. PubMed ID: 20538481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
    Kadoglou NP; Fotiadis G; Athanasiadou Z; Vitta I; Lampropoulos S; Vrabas IS
    Endocrine; 2012 Dec; 42(3):561-9. PubMed ID: 22407494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
    BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
    Alemzadeh R; Kichler J
    Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance.
    Ben Ali S; Belfki-Benali H; Ahmed DB; Haddad N; Jmal A; Abdennebi M; Romdhane HB
    Clin Exp Hypertens; 2016; 38(4):370-4. PubMed ID: 27149156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women.
    Faraj M; Messier L; Bastard JP; Tardif A; Godbout A; Prud'homme D; Rabasa-Lhoret R
    Diabetologia; 2006 Jul; 49(7):1637-46. PubMed ID: 16752182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment.
    Andrikoula M; McDowell IF
    Diabetes Obes Metab; 2008 Apr; 10(4):271-8. PubMed ID: 18333887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.